Abstract
Secondary pulmonary hypertension (sPH) may develop as a result of few systemic diseases as endocrine diseases, HIV infection, collagen diseases, liver and hematological disorders. In this review we discuss the role of systemic diseases in inducing PH starting from a pathological classification.
Keywords: endothelial nitric oxide synthase, calcitonin, copd, endothelin-1, vasoconstrictor, growth hormone, hiv, myeloid metaplasia
Current Drug Targets - Inflammation & Allergy
Title: Pulmonary Hypertension and Systemic Diseases
Volume: 3 Issue: 4
Author(s): Rossella Paolini, Michela Armigliato and Sergio Zamboni
Affiliation:
Keywords: endothelial nitric oxide synthase, calcitonin, copd, endothelin-1, vasoconstrictor, growth hormone, hiv, myeloid metaplasia
Abstract: Secondary pulmonary hypertension (sPH) may develop as a result of few systemic diseases as endocrine diseases, HIV infection, collagen diseases, liver and hematological disorders. In this review we discuss the role of systemic diseases in inducing PH starting from a pathological classification.
Export Options
About this article
Cite this article as:
Paolini Rossella, Armigliato Michela and Zamboni Sergio, Pulmonary Hypertension and Systemic Diseases, Current Drug Targets - Inflammation & Allergy 2004; 3 (4) . https://dx.doi.org/10.2174/1568010042634613
DOI https://dx.doi.org/10.2174/1568010042634613 |
Print ISSN 1568-010X |
Publisher Name Bentham Science Publisher |
Online ISSN 1568-010X |
Related Articles
-
Oxidative Stress and Endothelial Dysfunction in Cardiovascular Disease: Mitochondria-Targeted Therapeutics
Current Medicinal Chemistry Blockade of Diabetic Vascular Injury by Controlling of AGE-RAGE System
Current Drug Targets Inflammatory Biomarkers Predicting Events in Atherosclerosis
Current Medicinal Chemistry MicroRNA-mediated Regulation of Angiogenesis
Current Angiogenesis (Discontinued) Essential Hypertension, Cerebral White Matter Pathology and Ischemic Stroke
Current Medicinal Chemistry Recent Advances in α1-Adrenoreceptor Antagonists as Pharmacological Tools and Therapeutic Agents
Current Topics in Medicinal Chemistry Newly Diagnosed Dementia and Increased Risk of Hemorrhagic Stroke: A Nationwide Population-based Study
Current Alzheimer Research Airway Management in Pediatric Head and Neck Infections
Infectious Disorders - Drug Targets Neurocognitive Monitoring and Care During Pediatric Cardiopulmonary Bypass — Current and Future Directions
Current Cardiology Reviews A Population-Based Study of Cholesterol Measurements in the Oldest Old
Current Aging Science Neutrophil to Lymphocyte (N/L) and Platelet to Lymphocyte (P/L) Ratios in Differentiating Acute Heart Failure from Respiratory Infection
Current Vascular Pharmacology Targeted Therapies for Advanced Non-Small Cell Lung Cancer
Combinatorial Chemistry & High Throughput Screening Cardiorenal Consequences of Atherosclerosis and Statins Therapy: From the Past to the Future
Current Pharmaceutical Design Serum Uric Acid and Diabetes: From Pathophysiology to Cardiovascular Disease
Current Pharmaceutical Design The Second Generation of COX-2 Inhibitors: Clinical Pharmacological Point of View
Mini-Reviews in Medicinal Chemistry Von Willebrand Factor and Cardiovascular Disease: From a Biochemical Marker to an Attractive Therapeutic Target
Current Vascular Pharmacology Metabolic Syndrome, Mild Cognitive Impairment and Dementia
Current Alzheimer Research Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets Type 3 Diabetes Mellitus: A Novel Implication of Alzheimers Disease
Current Topics in Medicinal Chemistry Postoperative Care of the Transplanted Patient
Current Cardiology Reviews